Varco intends to recruit additional key opinion leaders in high-performing markets, scale up its business operations in the US and the UAE
Delhi based-health care startup, Varco Leg Care raised an undisclosed amount in the seed round led by Neeraj Garg, Ex-CEO, Hindustan Coca-Cola, Dr Mohit Lalvani Mascot Spincontrol India, Simple Juneja, Global Business leader, Ex-Coca-Cola, Bacardi, LVMH and other angels in medical, top consultant companies, FMCG and infrastructure.
Varco Leg Care plans to use its recent funding to broaden its range of products, with a particular focus on enhancing leg health. The company will invest in advanced technology to improve retention and discoverability, while simultaneously enhancing its distribution channels.
Varco intends to recruit additional key opinion leaders in high-performing markets, scale up its business operations in the US and the UAE, and allocate substantial resources to research and development efforts.
Speaking on the occasion, CEO, Varco Leg Care, Anondeep Ganguly said, “At Varco Leg Care, we have invested in a comprehensive research and development initiative to develop the first phyto-based leg care brand in Asia. Our Chief Scientific Officer, Dr Apurba Ganguly, has spearheaded this effort and has more than 100 clinical studies published in reputed medical journals, in addition to being a Member of the American Academy of Pain Medicine and the European Medical Association. We aim to become the leading brand in the sector, by focusing solely on addressing the actual requirements of leg care.”
“We are proud to announce the appointment of Dr Tapish Sahu as our Chief Medical Advisor. Dr Sahu is one of the country’s leading Vascular Surgeons and his guidance will be invaluable in developing our range of products. Under his guidance, we intend to take the KOL (Key Opinion Leader) route to cater to various conditions such as varicose veins, diabetic feet, and nail fungus leveraging advanced formulations and
proprietary phytotransdermal technology to provide cutting-edge solutions for end-to-end leg health challenges,” Ganguly added.
Neeraj Garg, Ex-CEO, Hindustan Coca-Cola said, “This is an excellent product that has been validated by scientific research not only in India but also in the US and Europe. While the online journey is progressing well, the ultimate goal is to establish distribution channels from D2C to a Phygital model to unlock its true commercial value. He strongly believes that within three-four years, this brand has the potential to generate $10 million in revenue.”
